Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: An open, single-centre study

Clinical and Experimental Dermatology

Volumn 27, Issue 8, 2002, Pages 641-644

  Patel, D C ^a   Evans, A V ^a   Hawk, John L M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INORGANIC COMPOUND; PSEUDOCATALASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOSAFETY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERANCE; FACE; FEMALE; HAND; HUMAN; MALE; PHOTOGRAPHY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; RASH; STANDARDIZATION; ULTRAVIOLET B RADIATION; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; CATALASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PHOTOCHEMOTHERAPY; ULTRAVIOLET THERAPY; VITILIGO;

EID: 0036454545     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2002.01142.x     Document Type: Article

References (6)

1. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure. Case study on 33 patients. Dermatology 1995; 190: 223-9.
2. Westerhof W. Vitiligo - A window in the darkness. Dermatology 1995; 190: 181-2.
3. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081-5.
4. Schallreuter KU, Pittelkow MR. Defective calcium uptake system in vitiligo. Arch Dermatol Res 1988; 280: 137-9.
5. Schallreuter KU, Wood JM, Pittelkow MR et al. High expression of beta-2-adrenoreceptors in differentiating lesional keratinocytes of vitiligo. Arch Dermatol Res 1993; 285: 216-20.
6. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-8.